Skip to main content

Cardinal Health Inc

corporate_fare Company Profile

Cardinal Health Inc

CAH·NYSE·Trade & Services·CIK 0000721371

Cardinal Health, Inc. is a global integrated healthcare services and products company. The company provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices worldwide. Cardinal Health operates through two reportable segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical drugs, over-the-counter healthcare products, and consumer products to customers across the healthcare continuum. This segment also provides nuclear pharmacy and related services, specialty pharmaceutical distribution, and medication management solutions. The Medical segment manufactures, sources, and distributes a broad portfolio of medical, surgical, and laboratory products. This includes Cardinal Health branded products, such as gloves, surgical apparel, and fluid management products, as well as products from other manufacturers. The Medical segment also offers services like supply chain management and kitting solutions for healthcare providers. Cardinal Health operates in numerous countries, serving a diverse customer base with essential healthcare products and services.

Cardinal Health Inc (NYSE:CAH) is a publicly traded company in the Trade & Services sector. Wiseek has independently scored 13 items for CAH at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-20, rated 7/10. Across its 13 most recent items scored 7 or higher, the top rating is 9/10, with 9 rated 8 or above. Recent SEC coverage for CAH spans 4, 10-K, 8-K, 10-Q.

Recent high-impact activity:

  • CEO Jason Hollar Sells $29.4M in Cardinal Health Shares
  • Cardinal Health FY26: Non-GAAP EPS $11.26, Guides FY27 Above Consensus; $5B Buyback Authorized
  • Cardinal Health Guides FY27 EPS Above Target, Authorizes $5B Buyback
  • Cardinal Health Delivers 70% EPS Jump, Guides FY27 Above Long-Term Target, and Authorizes $5B Buyback
  • Cardinal Health Q4 EPS Soars 70%, Guides FY27 Above Long-Term Target

Financial Snapshot

Fiscal year ended June 30, 2026
Revenue
$254.25B
Net Income
$1.71B
Diluted EPS
$7.23
Op. Cash Flow
$5.17B
Free Cash Flow
$4.53B
Gross Profit
$9.77B
Operating Income
$2.61B
Cash & Equivalents
$4.86B
Debt / Equity
0.00×
Net Margin
0.7%
Shares Outstanding
236M sh
Source: 10-K · filed 2026-08-11 · accession 0000721371-26-000038
Browse all tickers starting with C →
$234.57
52-week range · as of 2026-08-20 $145.87 – $258.3
Market cap
$54.56B
Volume
1.1M (0.6× avg)
3-mo avg 1.7M
Live data · 2026-09-12 18:26 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed CAH - Latest Insights

CAH
Aug 20, 2026, 7:33 AM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $233.08
Real-time Price: $234.57 info
Change: +$1.49 (+0.64%) info
Market Cap: $54.555B info
CAH
Aug 11, 2026, 8:57 AM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $238.62
Real-time Price: $234.57 info
Change: -$4.05 (-2%) info
Market Cap: $54.555B info
CAH
Aug 11, 2026, 8:15 AM EDT
Source: dpa-AFX
Importance Score:
9
Price at Filing: $238.00
Real-time Price: $234.57 info
Change: -$3.43 (-1%) info
Market Cap: $54.555B info
CAH
Aug 11, 2026, 6:47 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $248.67
Real-time Price: $234.57 info
Change: -$14.10 (-6%) info
Market Cap: $54.555B info
CAH
Aug 11, 2026, 6:45 AM EDT
Source: PR Newswire
Importance Score:
9
Price at Filing: $238.00
Real-time Price: $234.57 info
Change: -$3.43 (-1%) info
Market Cap: $54.555B info
CAH
Jul 20, 2026, 4:45 PM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $225.75
Real-time Price: $234.57 info
Change: +$8.82 (+4%) info
Market Cap: $54.555B info
CAH
May 01, 2026, 4:05 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $195.24
Real-time Price: $234.57 info
Change: +$39.33 (+20%) info
Market Cap: $54.555B info
CAH
Apr 30, 2026, 8:51 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $200.00
Real-time Price: $234.57 info
Change: +$34.57 (+17%) info
Market Cap: $54.555B info
CAH
Apr 30, 2026, 6:47 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $203.69
Real-time Price: $234.57 info
Change: +$30.88 (+15%) info
Market Cap: $54.555B info
CAH
Apr 30, 2026, 6:45 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $208.38
Real-time Price: $234.57 info
Change: +$26.19 (+13%) info
Market Cap: $54.555B info
CAH
Feb 05, 2026, 8:47 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $212.00
Real-time Price: $234.57 info
Change: +$22.57 (+11%) info
Market Cap: $54.555B info
CAH
Feb 05, 2026, 6:47 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $214.12
Real-time Price: $234.57 info
Change: +$20.45 (+10%) info
Market Cap: $54.555B info
CAH
Jan 13, 2026, 6:53 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $203.54
Real-time Price: $234.57 info
Change: +$31.03 (+15%) info
Market Cap: $54.555B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets